// App-Quantinova.ai

: HEALTHCARE RESOURCE UTILIZATION (HRU) ASSOCIATED WITH MINIMAL RESIDUAL DISEASE (MRD) STATUS IN ADULTS WITH B-CELL PRECURSOR (BCP) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

Researchers

Presenter

  • Arnaud Pigneux

Principal Investigators

  • Pau Montesinos

  • Ze Cong

  • Xinke Zhang

  • Anja K Pownell

  • Heather Wieffer

  • Jan McKendrick

Medical Centers

  • Service d’Hématologie Clinique et Thérapie Cellulaire, Univ.Bordeaux, INSERM U035,F-33000 Bordeaux,France

  • Hematology Department (Torre F, planta 7) Hospital Universitario La Fe Avinguda Fernando Abril Martorell,106 CP 46026 Valencia, Spain,Spain;CIBERONC, Instituto Carlos III,Madrid,Spain

  • Amgen Inc., 1 Amgen Center Dr., Thousand Oaks,CA 91320,United States

  • PRMA Consulting, Linea House, Harvest Crescent, Ancells Business Park, Fleet,Hampshire, GU51 2UZ,United Kingdom

  • PRMA Consulting, Linea House, Harvest Crescent, Ancells Business Park, Fleet,Hampshire, GU51 2UZ,United Kingdom;Faculty of Health, University of Technology Sydney,New South Wales,Australia

Locations

  • France

  • Spain

  • United States

  • United Kingdom

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved